Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Hellerup – page 91

1 458 clinical trials in Hellerup, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hellerup at a glance
1 458
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 458 trials in Hellerup

Open in trial search

Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:pharmaand GmbH

Ovarian cancer

Not recruiting

Study of olaparib, durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alrefimotide
  • Sponsor:Nordic Society Of Gynaecological Oncology Clinical Trial Unit

Colorectal cancer

Not recruiting

Study of organ preservation using chemoradiotherapy and transanal surgery compared to standard surgery in patients with early rectal cancer (STAR-TREC trial)

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:The University Of Birmingham

Neuroblastoma

Not recruiting

Study on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Bevacizumab
  • Sponsor:The University Of Birmingham

Elective surgery

Not recruiting

Study on Ephedrine and Rocuronium for Faster Muscle Relaxation in Patients Aged 80 and Above Undergoing Elective Surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Saline
  • Sponsor:Region Hovedstaden

Alcohol use disorder

Not recruiting

Study of Single Dose Psilocybin Treatment for Adults with Alcohol Use Disorder

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
  • Sponsor:Region Hovedstaden

Osteoarthritis

Not recruiting

Study on Tranexamic Acid for Reducing Blood Loss in Osteoarthritis Patients Undergoing Total Hip Replacement

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tranexamic Acid
  • Sponsor:Region Hovedstaden

Study on Synovial Hypertrophy in Patients with Hemophilia A Using Efanesoctocog Alfa Prophylaxis

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Efanesoctocog Alfa
  • Sponsor:Swedish Orphan Biovitrum AB (publ)

Study on the Safety of Decidua Stromal Cells for Patients with Steroid-Resistant Severe Acute Graft vs Host Disease

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Placenta-Derived Decidual Stromal Cells, Ex-Vivo Expanded
  • Sponsor:Oslo University Hospital HF

Study on the Effects of Finerenone for Patients with Type 2 Diabetes and Early Diabetic Cardiovascular Autonomic Neuropathy

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Steno Diabetes Center Copenhagen

Cystic fibrosis

Not recruiting

Study on the Safety and Tolerability of Elexacaftor, Tezacaftor, and Ivacaftor in Children with Cystic Fibrosis Aged 12 to Less Than 24 Months

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Elexacaftor
  • Sponsor:Vertex Pharmaceuticals Inc.

Muscular dystrophy

Not recruiting

Study on the Effects of Ribitol (BBP-418) in Patients with Limb Girdle Muscular Dystrophy Type 2I

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Ribitol
  • Sponsor:ML Bio Solutions Inc.

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Hellerup

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on cardiovascular diseases including studies of new treatments for heart failure, atrial fibrillation, and atherosclerosis.

  • Heart failure treatment optimization
  • Stroke prevention strategies
  • Hypertension management

Current research examines novel therapeutic approaches like colchicine for heart conditions and innovative anticoagulation treatments.

02 Metabolic Disorders

Comprehensive studies addressing obesity and weight management through innovative therapeutic approaches and lifestyle interventions.

  • Weight reduction treatments
  • Diabetes management
  • Metabolic health optimization

Multiple trials are evaluating new medications including CagriSema and dapiglutide for weight management.

03 Respiratory Medicine

Advanced research in respiratory diseases including studies on vaccines and treatments for various pulmonary conditions.

  • Influenza prevention
  • COPD management
  • Pulmonary fibrosis treatments

Investigations include innovative approaches to lung disease treatment and prevention strategies.

04 Dermatological Studies

Clinical research focusing on skin conditions including treatments for psoriasis and atopic dermatitis.

  • Psoriasis therapies
  • Hidradenitis suppurativa treatment
  • Innovative dermatological interventions

Studies evaluate new biological treatments and their effectiveness in chronic skin conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.